Company intelligence / Profile preview

Zeltiq Aesthetics

Pleasanton, California, United Statescoolsculpting.com ↗

Ownership: Private
Employees: ~700
Development stage: Commercial

Overview

Zeltiq’s CoolSculpting device received FDA clearance for numbing skin in 2010 and for non-invasive removal of love handle fat later that year. It was subsequently cleared for additional body areas including the stomach (2012), thighs (2014), upper arm and more. The system became the market leader in cryolipolysis-based body contouring by 2014[1]. Clinical results show effective reduction of localized adipose tissue with minimal side effects.

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

CoolSculpting

Commercial

Indications: Body contouring, Fat reduction

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Zeltiq Aesthetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zeltiq Aesthetics.

Explore the full profile